MEDP - Medpace Holdings - Stock Price & Dividends

Medpace Holdings, Inc. is a leading provider of clinical research-based drug and medical device development services, operating across North America, Europe, and Asia. The company's comprehensive suite of services supports the entire clinical development process, from Phase I to Phase IV, across various therapeutic areas.

Medpace offers a range of services tailored to the needs of the pharmaceutical, biotechnology, and medical device industries. These services include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance, new drug application submissions, and post-marketing clinical support. This enables clients to navigate the complex clinical development process efficiently and effectively.

In addition to its core services, Medpace provides specialized support for clinical trials, including bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support. This comprehensive approach enables clients to access a single, trusted partner for all their clinical development needs.

Founded in 1992, Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio, and has established itself as a trusted partner for companies seeking to bring innovative treatments and devices to market. With a strong track record of delivering high-quality services, Medpace is well-positioned to support the evolving needs of the life sciences industry.